Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Curon Stretta GERD Coverage Boost In 2005 Has Sales Force Salivating

This article was originally published in The Gray Sheet

Executive Summary

Curon Medical hopes to quintuple the reimbursement-eligible patient population for its minimally-invasive Stretta gastroesophogeal reflux disease (GERD) treatment by mid-2005

You may also be interested in...



GERD Device Maker’s Experience Exemplifies Coverage Barriers For Small Biz

Curon Medical's five-year battle to surpass 10% of U.S. public and private insurer coverage of its Stretta GERD therapy underscores the difficulties small companies face in navigating the reimbursement process

GNC In Rough Seas From COVID-19 Pandemic; Vitamin Shoppe Safe In Port Under New Owner

GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.

QUOTED. 7 April 2020. Surendar Magar.

California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.

UsernamePublicRestriction

Register

MT021206

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel